Osimertinib for Lung Squamous Cell Carcinoma: A Case Report and Literature Review

The efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in lung squamous cell carcinoma is said to be low. Thus far, only four cases of osimertinib in lung squamous cell carcinoma have been published. We experienced a case of EGFR mutant lung squamous cell carcinoma i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Yoshimatsu, Yuki, Ebi, Noriyuki, Ooi, Ryunosuke, Sueyasu, Takuto, Nishizawa, Saori, Munechika, Miyuki, Yoshimine, Kohei, Ko, Yuki, Ide, Hiromi, Tsuruno, Kosuke, Tobino, Kazunori
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079920/
https://ncbi.nlm.nih.gov/pubmed/33132329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5463-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados